CLDX compared with VERA: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

VERAVera Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

VERAVera Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CLDX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+0.36%×0.04

May 8 '26±7.6%▲+1.95%×0.25

Q1 FY26±13.6%▼−0.58%×0.04

Q3 FY25±17.3%▲+7.50%×0.43

VERA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.4%▼−4.08%×0.33

May 7 '26±8.7%▼−1.95%×0.22

= impliedCLDX realized, solidVERA realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±14.7%

▲+1.61%

×0.11

Q3 FY25±21.3%▼−1.03%×0.05

CLDXCelldex Therapeutics, Inc.

30.19▲+0.30%

Mkt cap$2.4BRevenue$22,000Q2 FY26Revenue$7MFY24

VERAVera Therapeutics, Inc.

31.88▲+2.91%

Regular sessionSep 2 '83

Mkt cap$2.2BRevenue—Revenue—

Compare

Regular sessionSep 2 '83

CLDXCelldex Therapeutics, Inc.

VERAVera Therapeutics, Inc.

30.19▲+0.30%

Price

31.88▲+2.91%

$2.4B

Mkt cap

$2.2B

Q2 FY26$22,000

Revenue

—

FY24$7M

Revenue

—

CLDX30.19▲+0.30%vsVERA31.88▲+2.91%Regular sessionSep 2 '83